Daytime Sleepiness in Patients With the Assessment of a Sleep-related Respiratory Disorder
NCT ID: NCT04448470
Last Updated: 2020-06-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
130 participants
OBSERVATIONAL
2020-06-24
2021-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sleep-related Breathing Disorders in Cardiological Outpatients
NCT02693925
The Severity Of Individual Breathing Cessation Events In Diagnostics Of Obstructive Sleep Apnea
NCT03232658
Diurnal Evaluation of OSA Upper Airway Collapsibility and Muscle Responsiveness
NCT06334601
Sleep Apnea and Periodic Breathing
NCT00936273
Is the Daytime Sleepiness Based on Epworth Sleepiness Scale a Good Way to Assess Taiwanese With Suspected Obstructive Sleep Apnea.
NCT04631783
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The following questions should be answered:
1. Does daytime sleepiness in patients with sleep apnea measured by a scale-based, psychometric time-series test show one or more characteristic patterns over the day?
2. Is there a relation between the degree of the scale based psychometric time series test for daytime sleepiness and the severity of sleep apnea?
3. Is the test quality of the scale based psychometric time series test for predicting sleep apnea better than the established Epworth Sleepiness Scale or STOP BANG questionnaires.
The quantification of daytime sleepiness can potentially be of crucial importance both for diagnostic procedures and for the assessment of the use of therapeutic measures.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patients with a clinical suspicion of sleep apnea (n=150)
patients with a clinical suspicion of sleep apnea
Questionnaire for recording daytime sleepiness over the course of the day
Questionnaire for recording daytime sleepiness over the course of the day
Anamnesis and physicial examination
Anamnesis and physical examination, e.g. medication, comorbidities, complaints
Questionnaire for quantifying daytime sleepiness
the Epworth Sleepiness Scale (ESS) questionnaire and the STOP BANG Questionnaire
Pulmonary function test
The measured values of spirometry/body plethysmography, CO diffusion and blood gas analysis are documented, if available.
Polygraphy
Polygraphy is a non-invasive portable examination method that the patient uses in the home environment at night to measure possible sleep-related breathing disorders. Typically, the following measurement signals are recorded: nasal airflow, thoracic and abdominal breathing excursions, snoring and breathing sounds via a microphone, pulse, oxygen saturation and position. The evaluation results and the findings are checked by a physician. Essential parameters include the apnoea-hypopnoea index, the number of obstructive, central and mixed apnoea/hypopnoea, the number and duration of desaturation, snoring or the association with a certain position.
healthy subjects (n=10)
healthy subjects
Questionnaire for recording daytime sleepiness over the course of the day
Questionnaire for recording daytime sleepiness over the course of the day
Anamnesis and physicial examination
Anamnesis and physical examination, e.g. medication, comorbidities, complaints
Questionnaire for quantifying daytime sleepiness
the Epworth Sleepiness Scale (ESS) questionnaire and the STOP BANG Questionnaire
Pulmonary function test
The measured values of spirometry/body plethysmography, CO diffusion and blood gas analysis are documented, if available.
Polygraphy
Polygraphy is a non-invasive portable examination method that the patient uses in the home environment at night to measure possible sleep-related breathing disorders. Typically, the following measurement signals are recorded: nasal airflow, thoracic and abdominal breathing excursions, snoring and breathing sounds via a microphone, pulse, oxygen saturation and position. The evaluation results and the findings are checked by a physician. Essential parameters include the apnoea-hypopnoea index, the number of obstructive, central and mixed apnoea/hypopnoea, the number and duration of desaturation, snoring or the association with a certain position.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaire for recording daytime sleepiness over the course of the day
Questionnaire for recording daytime sleepiness over the course of the day
Anamnesis and physicial examination
Anamnesis and physical examination, e.g. medication, comorbidities, complaints
Questionnaire for quantifying daytime sleepiness
the Epworth Sleepiness Scale (ESS) questionnaire and the STOP BANG Questionnaire
Pulmonary function test
The measured values of spirometry/body plethysmography, CO diffusion and blood gas analysis are documented, if available.
Polygraphy
Polygraphy is a non-invasive portable examination method that the patient uses in the home environment at night to measure possible sleep-related breathing disorders. Typically, the following measurement signals are recorded: nasal airflow, thoracic and abdominal breathing excursions, snoring and breathing sounds via a microphone, pulse, oxygen saturation and position. The evaluation results and the findings are checked by a physician. Essential parameters include the apnoea-hypopnoea index, the number of obstructive, central and mixed apnoea/hypopnoea, the number and duration of desaturation, snoring or the association with a certain position.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Written informed consent to participate in this study
* Patients with a clinical suspicion of sleep apnea
* Age 18-45 years
* no internal or psychiatric illness requiring therapy
* not long-term drug therapy
* no known sleep apnea.
* Written consent to participate in this study
Exclusion Criteria
* Lack of consent to participate in the study
* Lack of willingness and ability to participate in the study
* Pregnancy and breast feeding period
* Patients with sleep apnea
* Age \<18 years or ≥ 45 years
* Lack of consent to participate in the study
* Pregnancy and breast feeding period
* Lack of willingness and ability to participate in the study
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Heinrich-Heine University, Duesseldorf
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Klinik für Kardiologie, Pneumologie und Angiologie
Principle Investigator Dr. Stefanie Keymel
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Malte Kelm, Prof. Dr.
Role: STUDY_CHAIR
Heinrich-Heine University, Duesseldorf
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Heinrich-Heine-University
Düsseldorf, North Rhine-Westphalia, Germany
Lung and Allergy Centre
Neuss, North Rhine-Westphalia, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Johannes Uerscheln, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
19-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.